Background: To augment cement-bone fixation, Dr. Hironobu Oonishi attempted additional physicochemical bonding through interposition of osteoconductive crystal hydroxyapatite (HA) granules at the cement-bone interface in 1982. He first used the interface bioactive bone cement (IBBC) technique in 12 selected patients (12 hips) in 1982 (first stage) and followed them for 2 years. In 1985, the technique was applied in 25 total hip arthroplasty (THA) patients (second stage) and the effects were investigated by comparing the side with the IBBC technique and the other side without the IBBC technique. He has employed this technique in all THA patients since 1987 (third stage).

Methods: In the IBBC technique, HA granules (2 to 3 g) were smeared on the bone surface just before the acetabular and femoral components were cemented. In the first stage, 12 hips were operated using the IBBC technique in 1982. In the second stage, THA was performed without the IBBC technique on one side and with the IBBC technique on the other side within 1 year in 25 patients. In the third stage, THA was performed with the IBBC technique in 285 hips in 1987.

Results: In the first stage patients, implant loosening was not detected at 30 years after operation. In the second stage patients, revision was required in 7 hips without the IBBC technique due to cup loosening (5 hips) and stem loosening (2 hips), whereas no hip was revised after THA with the IBBC technique at 26 years after operation. In the third stage patients, the incidence of radiolucent lines and osteolysis was very few at 25 years after operation.

Conclusions: The long-term follow-up of THA performed around the inception of the IBBC technique has revealed low incidences of radiolucent lines, osteolysis, and revision surgery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987305PMC
http://dx.doi.org/10.4055/cios.2016.8.3.237DOI Listing

Publication Analysis

Top Keywords

ibbc technique
44
technique
14
second stage
12
side ibbc
12
technique side
12
tha performed
12
stage patients
12
ibbc
11
total hip
8
hip arthroplasty
8

Similar Publications

Background: Positive effects of early nutritional strategies on neurological outcomes have been observed when nutrients were administered by the enteral route, especially during the first week of life. Evidence reports that serum neurofilament light chain (NfL), a structural protein of neurons, is a specific and reliable biomarker of neuronal damage.

Objective: The present study aimed to investigate the effect of early enteral nutrition (EN) in minimizing neuroaxonal damage and assessing NfL serum levels in preterm neonates.

View Article and Find Full Text PDF

Purpose: Sentinel lymph node biopsy (SLNB) has been recognized as "the gold standard" for axillary staging in early breast cancer patients with clinically negative lymph nodes, resulting in significant morbidity decrease and quality of life improvement. This study aims to validate the performance of a newly developed handheld portable gamma camera (PGC) produced by Imagensys (Italy), in detecting and locating sentinel lymph nodes (SLNs) during the preoperative and intraoperative phases in breast cancer patients compared to conventional lymphoscintigraphy.

Methods: Adult female patients with histologically confirmed breast cancer, candidates for surgery and SLNB, were prospectively enrolled in this open-label, pre-marketing clinical trial.

View Article and Find Full Text PDF

Drinking alcohol during pregnancy can cause congenital disabilities. J. Roquette, P.

View Article and Find Full Text PDF
Article Synopsis
  • Bronchiolitis is a common viral infection in infants that can lead to serious complications, but there are currently no definitive lab tests to gauge severity, aside from demographic factors.
  • This study investigated the levels of Brain-Derived Neurotrophic Factor (BDNF) in the serum of infants with bronchiolitis at discharge, finding that those with severe cases had significantly lower BDNF levels.
  • The research suggests that low serum BDNF may indicate either increased use by lung cells or decreased production by those cells, highlighting the need for further investigation into this biomarker's role in disease severity.
View Article and Find Full Text PDF
Article Synopsis
  • - Axitinib, a drug used for advanced kidney cancer, is being tested for effectiveness against glioblastoma, a severe brain tumor, and shows improved results when combined with other treatments
  • - Research indicates that axitinib can lead to cellular senescence (aging) in both tumor and normal cells, but using the antioxidant N-Acetyl-L-Cysteine (NAC) may limit this effect in normal cells while preserving its anti-cancer properties
  • - The study reveals that NAC combined with axitinib enhances blood vessel health in brain tumors and protects against liver damage from axitinib, suggesting a potential for better treatment outcomes with reduced side effects
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!